Mark A Morgan Selected Research

Fallopian Tube Neoplasms

9/2008

Paclitaxel poliglumex and carboplatin as first-line therapy in ovarian, peritoneal or fallopian tube cancer: a phase I and feasibility trial of the Gynecologic Oncology Group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark A Morgan Research Topics

Disease

27	Neoplasms (Cancer) 06/2022 - 06/2005
12	Ovarian Neoplasms (Ovarian Cancer) 12/2022 - 02/2002
11	Carcinoma (Carcinomatosis) 01/2021 - 04/2006
7	Endometrial Neoplasms (Endometrial Cancer) 06/2022 - 01/2020
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 01/2002
3	Carcinosarcoma 04/2022 - 09/2020
3	Thrombocytopenia (Thrombopenia) 12/2019 - 04/2003
2	Anemia 12/2022 - 12/2019
2	Neutropenia 12/2022 - 05/2011
2	Ovarian Epithelial Carcinoma 01/2022 - 08/2003
2	Lymphatic Metastasis 09/2021 - 01/2021
2	Leiomyosarcoma 09/2021 - 04/2003
2	Endometrial Stromal Sarcoma 09/2021 - 01/2020
2	Endometrioid Carcinoma 06/2021 - 01/2020
2	Adenocarcinoma 01/2021 - 01/2020
2	Fistula 05/2009 - 11/2004
1	Sarcoma (Soft Tissue Sarcoma) 09/2021
1	Adenosarcoma 09/2021
1	Vulvar Neoplasms (Vulvar Cancer) 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Adenosquamous Carcinoma 01/2021
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2020
1	Fatigue 12/2019
1	Nausea 12/2019
1	Granulosa Cell Tumor 05/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2017
1	Cytokine Release Syndrome 01/2017
1	Residual Neoplasm 12/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2015
1	Diphtheria 05/2012
1	Bladder Exstrophy (Exstrophy, Bladder) 10/2009
1	Acidosis 10/2009
1	Vesicovaginal Fistula 10/2009
1	Fecal Incontinence 04/2009
1	Fallopian Tube Neoplasms 09/2008
1	Cellulitis 04/2006
1	Wounds and Injuries (Trauma) 04/2006
1	Lymphedema (Milroy Disease) 04/2006
1	Colorectal Neoplasms (Colorectal Cancer) 12/2005
1	Infections 06/2005
1	Pelvic Organ Prolapse 05/2005

Drug/Important Bio-Agent (IBA)

5	PlatinumIBA 12/2022 - 02/2002
5	Paclitaxel (Taxol)FDA LinkGeneric 12/2019 - 04/2003
4	Carboplatin (JM8)FDA LinkGeneric 12/2019 - 09/2008
2	Peptides (Polypeptides)IBA 01/2020 - 05/2012
2	CreatinineIBA 10/2009 - 04/2003
1	rucaparibIBA 12/2022
1	veliparibIBA 12/2019
1	Adenosine Diphosphate (ADP)IBA 12/2019
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 12/2019
1	Tumor Biomarkers (Tumor Markers)IBA 12/2018
1	Metronidazole (Metric)FDA LinkGeneric 01/2018
1	Neomycin FDA LinkGeneric 01/2018
1	Vancomycin FDA LinkGeneric 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	InterferonsIBA 01/2017
1	MesothelinIBA 01/2017
1	CytokinesIBA 01/2017
1	C-Reactive ProteinIBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	Chimeric Antigen ReceptorsIBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2015
1	Mitochondrial DNA (mtDNA)IBA 10/2015
1	VaccinesIBA 10/2015
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 10/2015
1	AZD 6244IBA 02/2013
1	CRM197 (non-toxic variant of diphtheria toxin)IBA 05/2012
1	Proteins (Proteins, Gene)FDA Link 05/2012
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2012
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 05/2012
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2011
1	paclitaxel poliglumex (XYOTAX)IBA 09/2008
1	insulin receptor-related receptor (IRR)IBA 03/2007
1	Tamoxifen FDA LinkGeneric 12/2005
1	DNA (Deoxyribonucleic Acid)IBA 06/2005
1	Glycoproteins (Glycoprotein)IBA 06/2005
1	Thromboplastin (Tissue Factor)IBA 06/2005
1	Viral DNAIBA 06/2005
1	AntigensIBA 06/2005
1	Dietary Fiber FDA Link 05/2005

Therapy/Procedure

15	Lymph Node Excision (Lymph Node Dissection) 06/2022 - 04/2006
14	Hysterectomy 06/2022 - 01/2020
12	Drug Therapy (Chemotherapy) 12/2022 - 01/2008
10	Therapeutics 04/2022 - 04/2003
8	Radiotherapy 06/2022 - 01/2002
7	Adjuvant Chemotherapy 06/2022 - 01/2019
2	Urinary Diversion (Ileal Conduit) 10/2009 - 05/2009
1	Brachytherapy 06/2022
1	Laparotomy 01/2021
1	Adjuvant Radiotherapy 01/2021
1	Minimally Invasive Surgical Procedures 09/2020
1	Salpingo-oophorectomy 01/2020
1	Induction Chemotherapy 12/2019
1	Operative Time 01/2019
1	Aftercare (After-Treatment) 01/2017
1	Cytoreduction Surgical Procedures 12/2016
1	Immunotherapy 10/2015
1	Operative Surgical Procedures 04/2009
1	Ligation 04/2006